AMR and AMU Surveillance in Singapore

Surveillance of AMR and antimicrobial utilisation (AMU) is essential to understand the magnitude, distribution, and impact of resistant organisms and antimicrobial use. Regular monitoring of resistance trends, associations between usage and resistance, and outcomes of policies and initiatives to combat AMR can enable a timely and appropriate response to AMR.

AMRCO coordinates the publication of the biennial One Health Report on Antimicrobial Utilisation and Resistance, drives the Primary Care AMU Surveillance Initiative and collates Singapore’s data for global reporting. More information on these initiatives can be found below.

One Health AMR and AMU Surveillance

AMR surveillance programmes need a One Health approach, considering how AMR develops and transmits across the human, animal, food and environment sectors, e.g. through the movement of people, animals, food, and water contamination.

The biennial One Health Report on Antimicrobial Utilisation and Resistance is a collaboration between CDA, NEA, NParks, PUB, and SFA. The multi-sectoral surveillance report provides key findings of national AMR surveillance programmes, including surveillance on the utilisation and sales of antimicrobials in the human and animal health sectors, and the incidence and resistance proportions of priority AMR organisms found in humans, animals, food, and the environment.

Read previous One Health Reports below:

• One Health Report on Antimicrobial Utilisation and Resistance, 2021

• One Health Report on Antimicrobial Utilisation and Resistance, 2019

• One Health Report on Antimicrobial Utilisation and Resistance, 2017

Primary Care Antimicrobial Utilisation Surveillance Initiative

Launched in 2021, the Primary Care AMU Surveillance Initiative (GP-AMU) monitors AMU trends in communities through analysing and reviewing AMU data contributed by participating general practitioner (GP) clinics. In turn, GP-AMU facilitates data-driven feedback annually for participating GP clinics' internal monitoring.

Learn more about GP-AMU here.

Contact us at amrco@cda.gov.sg if you are interested to participate in this initiative.

Participation in Global Surveillance

In 2019, Singapore enrolled in the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS), the first global collaborative effort to standardise AMR surveillance. Singapore has been contributing AMR data from sentinel healthcare facilities through AMRCO, the appointed GLASS National Coordinating Centre.

Learn more about WHO GLASS here.

The GLASS dashboard presents global AMR data for countries, territories, and areas enrolled in GLASS. View the GLASS dashboard here.